MedDataX Logo

Comparison of Retinal Nerve Fiber Layer (RNFL) Thickness Measurements by Time-Domain and Spectral-Domain OCT In Glaucoma Patients

NCT ID: NCT00773877

Last Updated: 2008-10-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-10-31

Study Completion Date

2008-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Measurement of RNFL thickness by OCT is at a cornerstone for the correct diagnosis and monitoring of progression of glaucomatous optic neuropathy.

Spectral domain technology has enabled better reproducibility with better axial resolution in the measurement of RNFL thickness. A comparative study among Stratus, Cirrus and RT-View will enable clinicians to determine differences among various instruments.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Open Angle Glaucoma

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

RNFL thickness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Primary open angle glaucoma

No interventions assigned to this group

2

Normal Controls

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

* Evidence of retinal disease
* Secondary glaucoma due to intraocular inflammation
* Lens induced glaucoma
* Neovascular glaucoma
* Tumor induced glaucoma
Minimum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Yonsei University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Institute of Vision Research, Department of Ophthalmology, Severance Hospital, Yonsei University School of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institute of Vision Research, Department of Ophthalmology, Severance Hospital, Yonsei University School of Medicine

Seoul, , South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Chan Yun Kim, MD,PhD

Role: CONTACT

Phone: 82-2-2228-3570

Email: [email protected]

Sung Yong Kang, MD

Role: CONTACT

Phone: 82-2-2228-3570

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Chan Yun Kim, MD,PhD

Role: primary

Sung Yong Kang, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4-2008-0342

Identifier Type: -

Identifier Source: org_study_id